Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Oligometastatic Prostate Cancer × Androgen Antagonists × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 47 Neoplasm Metastasis 2 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 2 Triple Negative Breast Neoplasms 1 Stage IV Prostate Adenocarcinoma AJCC v7 1 Prostate CA 1 Prostate Adenocarcinoma 1 PSA Level Greater Than 0.03 1 Oligometastatic Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer 1 Lymphatic Metastasis 1 Hormone Sensitive Prostate Cancer 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

zimberelimab 1 quemliclustat 1 Radiosurgery 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03940235 2023-06-28

RADIOSA

European Institute of Oncology

Phase 2 Unknown

Oligometastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡